CENTER VALLEY, Pa. -- Aesculap, Inc. announced today that it has
been awarded a 36-month multi-source agreement with Novation for a broad
range of general, neurosurgery and endoscopic products. The recently signed
agreement is the first Surgical Instrument contract Aesculap has earned with
Novation, the supply company for VHA Inc. and University HealthSystem
Consortium (UHC), two national healthcare alliances.
Under terms of the agreement, Novation's VHA and UHC members can now access
a complete array of Aesculap's general and specialty surgical instruments,
repair and refurbishing, laparoscopic instruments, and YasargilTM aneurysm
clips at cost-effective pricing and terms, as well as Aesculap's world-class
service and support.
"We are pleased to have been selected by the VHA and UHC members of Novation
and look forward to working hand-in-hand with its members to help them
maximize the benefit of this new agreement," said Dirk Kuyper, chief
operating officer of Aesculap. "This agreement will provide us with the
opportunity to expand our relationships and grow our business with one of
the largest and most prestigious group purchasing organizations in the U.S."
Through this agreement, VHA and UHC members will have access to Aesculap's
Surgical Quality Management (SQM) program, a comprehensive quality
management solution that addresses all aspects of surgical services.
Surgical Quality Management provides a roadmap for evaluating, improving and
expanding the surgical efficiency and quality for any institution -- from
community hospitals to the world's largest teaching institutions. Elements
of the program include surgical asset management, operations and supply
chain management, and education and implementation.
"Our focus is to provide VHA and UHC healthcare organizations with the
lowest total delivered cost on the highest-quality products so they can
deliver high-quality cost-effective healthcare," said Zee Robertson,
Novation senior director, surgical service line. "Aesculap offers a good
balance between quality instruments and cost effectiveness."
Canada Faces Rising Measles Cases: Public Health Urges Vaccination Amid Growing Threat
March 6th 2025Measles cases in Canada are rising, with 227 infections reported in early 2025. Public health officials urge vaccination to prevent outbreaks, severe complications, and further community transmission.
Surging Whooping Cough Cases Highlight the Importance of Vaccination
March 6th 2025Experts like Michael Glazier, MD, warn that waning immunity, declining vaccination rates, and increased transmission are driving this resurgence. Vaccination remains the best defense, with pediatricians urging timely immunization to protect vulnerable populations and prevent further outbreaks.
Measles Outbreak Sparks APIC’s Urgent Call for Stronger Vaccine Policies
March 4th 2025The recent measles-related death in Texas has reignited fears about the consequences of declining vaccination rates and misinformation. Once declared eliminated in the US, measles is resurging with over 150 cases and climbing. APIC warns: this crisis is preventable—but only if we act now.